ÿþ

YV-18 YV-19 YV-20 HALS Surgrx Enseal System 5 29 16:10 17:10 1-1 YP-1 YP-2 YP-3 YP-4 YP-5 YP-6 1 20 TS1 2 5 29 16:10 17:10 1-2 YP-7 YP-8 YP-9 YP-10 YP-11 YP-12 1 IPMN 1 4 3 2 Gemcitabine 5 29 16:10 17:10 1-3 YP-13 1-47 -

YP-14 YP-15 YP-16 1 2 3 1 YP-17 5 30 15:55 16:55 2-1 YP-18 YP-19 YP-20 1 1 YP-21 YP-22 2 5 30 15:55 16:55 2-2 YP-23 1 YP-24 YP-25 YP-26 YP-27 Stage IVa PD 10 1 TACE TS1 YP-28 2 1 5 30 15:55 16:55 2-3 YP-29-48 -

YP-30 YP-31 YP-32 YP-33 YP-34 2 2 CA19-9 1 1 5 29 16:10 17:10 1-1 YP-35 YP-36 YP-37 YP-38 YP-39 Paclitaxel HbsMPC polymer SNP FGFR fibroblast growth factor receptor 2 5 29 16:10 17:10 1-2 YP-40 YP-41 YP-42 YP-43 YP-44 YP-52 hepcidin Methionine adenosyltransferase A2 discarded marginal donors rescue Magnetic Resonance Imaging - 49 -

5 30 15:55 16:55 1-3 YP-45 YP-46 YP-47 Cap43/NDRG1 YP-48 NOMI 2 YP-49 2 5 30 15:55 16:55 2 YP-50 S100A4 YP-51 High-mobility group protein HMGB 1 YP-53 YP-54 CD4+CD25+FoxP3+ T CT 5 29 16:10 17:10 1-1 YP-55 C IFN SVR 6 YP-56 YP-57 YP-58 B C HCV YP-59 YP-60 ROC 2 YP-61-50 -

5 29 16:10 17:10 1-2 YP-62 YP-63 YP-64 YP-65 YP-66 YP-67 YP-68 ADAMTS13UL-VWFM HMGB-1 RAGE TissueLink monopolar devise TM P-107 Transjugular intrahepatic portsystemic shunt TIPS1 5 29 16:10 17:10 2-1 YP-69 YP-70 YP-71 YP-72 YP-73 YP-74 CPT-11+S-1 II LC MCN IPMN 5 30 15:55 16:55 2-2 YP-75 YP-76 YP-77 KL-6 MUC1 KL-62 Fascin PET/CT - 51 -

YP-78 YP-79 YP-80 FDG-PET/CT ICG PDE TS-1 5 30 15:55 16:55 2-3 YP-81 YP-82 immunonutrition YP-83 YP-84 YP-85 3 5 30 15:55 16:55 3-1 YP-86 YP-87 Gemcitabine+CDDP GC YP-88 YP-89 TS-1 5 30 15:55 16:55 3-2 YP-90 ERCP YP-91 YP-92 YP-93 CD44 YP-94 Na + /H + exchanger FR183998-52 -

5 29 16:10 17:10 1 1 P-1 HCC P-2 P-3 RFA P-4 P-5 2cm P-6 P-7 5 29 16:10 17:10 2-1 1 P-8 P-9 P-10 P-11 IFN 1 P-12 C 151 P-13 1 P-14 1HCC 1 5 29 16:10 17:10 2-2 P-15 ITP 1 P-16 1-53 -

P-17 1 P-18 P-19 C SVR 10 1 P-20 1 P-21 1 5 29 16:10 17:10 3-1 P-22 C 3cm P-24 Belghiti s liver hanging maneuver3 P-25 1 P-26 1 P-27 1 P-28 P-29 14 5 29 16:10 17:10 3-2 P-30 AFP 1 P-31 1 P-32 1 P-33 P-34 P-35 B 2-54 -

5 29 16:10 17:10 4-1 2 P-36 1 P-37 1 P-38 IFNSVRC3 P-39 B P-40 P-41 1 5 29 16:10 17:10 4-2 P-42 1 P-43 1 P-44 2 P-45 1 P-46 P-47 5 29 16:10 17:10 1-1 P-48 P-49 2 P-50 S 1 P-51-55 -

P-52 Degradable Starch Microsphere 3 P-53 11 5 29 16:10 17:10 1-2 P-54 1 P-55 P-56 3 S 1 P-57 P-58 TEM 1 P-59 5 29 16:10 17:10 2-1 P-60 P-61 S 1 P-62 P-63 1 P-64 P-65 5 29 16:10 17:10 2-2 1 P-66 H3 P-67 sm 3 P-68-56 -

P-69 P-70, 5 29 16:10 17:10 1-1 P-71 1 P-72 P-73 1 P-74 1 P-75 P-76 5 30 15:55 16:55 1-2 P-77 CA19-9 P-78 1 P-79 PET granulomatous abscess 1 P-80 1 P-81 Peliosis hepatis 1 5 30 15:55 16:55 2 P-82 1 P-83 P-84 P-85 1-57 -

P-86 inflammatory pseudotumor 3 P-87 5 30 15:55 16:55 1 P-90 Danaparoid sodium P-91 2 P-92 1035 P-93 5 30 15:55 16:55 P-94 PTPE P-95 58 P-96 Tc-99m-GSA 1 P-97 P-98 longitudinal spread MDCT cholangiography direct cholangiography 5 30 15:55 16:55 P-99 volumetry PTPE P-100 1 P-101 SPECT-CT fusion P-102 1 P-103 Vv3 out.ow block - 58 -

P-104 Microwave coagulation 2 5 30 15:55 16:55 P-105 S4 S5 S8 1 P-106 2 P-108 P-109 2 P-110 IVR IIIb 1 P-111 1 5 30 15:55 16:55 P-112 P-113 P-114 FNH: Focal nodular hyperplasia 1 P-115 1 P-116 1 P-117 5 30 15:55 16:55 P-118 VAHS P-119 P-120 30 P-121 1-59 -

P-122 PSC 2 P-123 B ABO 1 P-124 5 30 15:55 16:55 SSI NTT P-125 P-126 P-127 P-128 SSI P-129 SSI NTT 5 30 15:55 16:55 P-130 NST P-131 immunonutrition P-132 P-133 DPC P-134 0 5 30 15:55 16:55 P-135 1 P-136 P-137 CR 1 P-138-60 -

P-139 RFA 1 P-140 P-141 1 5 30 15:55 16:55 P-142 91 P-143 PTCD 1 P-144 1 P-145 C 1 P-146 P-147 5 30 15:55 16:55 P-148 1 P-149 P-150 A 1 P-151 SLE 1 P-152 1 P-153 NASH 5 29 16:10 17:10 1 P-154 B4 P-155 6 1-61 -

P-156 peribiliary cyst P-157 1 P-158 IPNB 2 JA 5 29 16:10 17:10 2 P-159 IPNB 1 P-160 1 P-161 1 P-162 5 P-163 intraductal oncocytic papillary carcinoma 5 29 16:10 17:10 P-164 A2 A3 A4 1 P-165 20 P-166 SMA HPD 1 P-167 5 2 P-168 1 P-169 P-170 2 5 29 16:10 17:10 1 P-171 C 2 P-172 1-62 -

P-173 P-174 P-175 P-177 5 29 16:10 17:10 2 P-178 1 P-179 3 PTBD 1 P-180 P-181 1 P-182 A Case of Solitary Liver Metastasis from Bile Duct Carcinoma P-183 P-184 3 1 5 29 16:10 17:10 1 P-185 1 P-186 P-187 P-188 P-189 P-190 P-191-63 -

5 29 16:10 17:10 2-1 P-192 P-193 4 P-194 pitfall P-195 2 P-196 P-197 PET/CT 2 P-198 4 1 P-199 5 29 16:10 17:10 2-2 P-200 1 P-201 Malignant fibrous histiocytoma P-202 1 P-203 1 P-204 1 P-205 IPMN 1 P-206 1 5 29 16:10 17:10 1 P-207 #16 1 P-208-64 -

P-209 Virchow 2 3 P-210 1 P-211 P-212 P-213 5 29 16:10 17:10 2 P-214 EMA1 P-215 1 P-216 1 P-217 1 P-218 P-219 4 1 P-220 1 5 29 16:10 17:10 1 P-221 P-222 P-223 P-224 P-225 P-226 1 P-227-65 -

5 29 16:10 17:10 2-1 P-228 P-229 P-230 P-231 22 1 P-232 5 29 16:10 17:10 2-2 P-233 2 P-235 P-236 P-237 P-238 5 29 16:10 17:10 2-3 P-239 1 P-240 P-241 m 5 P-242 P-243 P-244 Vibrio cholerae non-011-66 -

5 30 15:55 16:55 1-1 P-245 1 P-246 2 P-247 1 P-248 P-249 P-250 3 5 30 15:55 16:55 1-2 P-251 P-252 1 P-253 1 P-254 2 P-255 2 P-256 3 5 30 15:55 16:55 2 P-257 5 P-258 Lemmel P-259 Lemmel 2 P-260 1 P-261 1-67 -

P-262 P-263 5 30 15:55 16:55 P-264 P-265 Mirizzi 1 P-266 P-267 Biliary ablation 1 P-268 1 P-269 Retrograde transhepatic biliary drainage PTBD 1 5 30 15:55 16:55 P-270 P-271 1 P-272 1 P-273 1 1 P-274 1 P-275 Angio-CT P-276 IgG4 1 P-277 IgG4 1 5 30 15:55 16:55 P-278-68 -

P-279 1 P-280 P-281 8 1 P-282 1 P-283 choledochocele 1 P-284 P-285 5 30 15:55 16:55 P-286 80 P-287 Mirizzi 1 P-288 Mirizzi 6 P-289 Bouveret's syndrome P-290 1 P-291 1 P-292 1 5 30 15:55 16:55 Vater 1 P-293 P-294 P-295 P-296-69 -

P-297 Vater 1 2 P-298 1 P-299 2 5 30 15:55 16:55 Vater 2-1 P-300 1 P-301 1 P-302 1 P-303 1 P-304 5 1 5 30 15:55 16:55 Vater 2-2 P-305 P-306 P-307 1 P-308 1 P-309 5 30 15:55 16:55 P-310 long SD P-311 Gemcitabine JA P-312 Stage4b TS-1 P-313 Gemcitabine 1-70 -

P-314 GEM /CAP P-315 gemcitabine 5 29 16:10 17:10 P-316 FDG-PET/CT P-317 FDG-PET P-318 FDG-PET P-319 diffusion weighted imaging ; DWI P-320 P-321 5 29 16:10 17:10 1 P-322 P-323 P-324 pn0 P-325 P-326 P-327 2 5 29 16:10 17:10 1 P-328 1 P-329 TS11 P-330-71 -

P-331 1 P-332 MDCT 1 P-333 Stage IVa 1 5 29 16:10 17:10 2 P-334 2 3 11 P-335 5 Stage IVb P-336 S-11 JA P-337 2 P-338 2 P-339 pancreatic acinar cell carcinoma 3 5 29 16:10 17:10 3 P-340 Groove 1 P-341 TS1 P-342 1 P-343 1 P-344 PanINs P-345 1 P-346 29 1 5 29 16:10 17:10 3 P-347-72 -

P-348 1 P-349 JA P-350 duct-islet cell carcinoma 1 P-351 1 P-352 1 5 29 16:10 17:10 IPMN1-1 P-353 IPMN P-354 P-355 IPMN P-356 IPMN P-357 IPMN P-358 2 1 P-359 IPMN 3 1 5 29 16:10 17:10 IPMN1-2 P-360 IPMN 3 P-361 IPMN 2 P-362 IPMT 8 P-363 1 P-364 IPMN 2 P-365 IPMN P-366 GIST IPMT 1-73 -

5 29 16:10 17:10 IPMN2 P-367 10 1 P-368 6 P-369 IPMN P-370 1 P-371 2 3 P-372 IPNM P-373 1 P-374 MCN1 5 29 16:10 17:10 1 P-375 PD DGEPPPD SSPPD P-376 P-377 P-378 P-379 J-VAC P-380 T P-381 5 29 16:10 17:10 1 P-382 PD P-383-74 -

P-384 CEZ CTM P-385 P-386 3 P-387 2 5 29 16:10 17:10 2-1 P-388 P-389 Appleby1 P-390 P-391 2 P-392 P-393 3 5 29 16:10 17:10 2-2 P-394 P-395 P-396 1 P-397 Appleby P-398-75 -

5 30 15:55 16:55 P-399 P-400 PpPD P-401 1 P-402 P-403 PpPD P-404 5 30 15:55 16:55 1 P-405 P-406 2 IVR 1 P-407 P-408 16 P-409 2 P-410 12 1 5 30 15:55 16:55 2 P-411 1 P-412 2 P-413 P-414 P-415 1-76 -

P-416 ASVS 2 5 30 15:55 16:55 3 P-417 15 1 P-418 P-419 1 P-420 2 P-421 MEN 5 30 15:55 16:55 P-422 2 P-423 2 P-424 1 P-425 1 P-426 11 1 P-427 5 30 15:55 16:55 P-428 1 P-429 IPACC P-430 P-431 1 P-432 1-77 -

P-433 solid pseudopapillary tumor SPT 2 P-434 12 solid pseudopapillary tumor 5 30 15:55 16:55 1 P-435 Dermoid cyst P-436 1 P-437 1 P-438 2 P-439 1 P-440 solid pseudopapillary tumor 1 P-441 5 30 15:55 16:55 2 P-442 solid pseudopapillay tumor 1 P-443 1 P-444 lymphoepithelial cyst 1 P-445 Dermoid cyst 1 P-446 lymphoepithelial cysts 5 30 15:55 16:55 P-447 1 P-448 1 P-449 IPMT lymphoepithelial cyst 1-78 -

P-450 2 P-451 1 P-452 P-453 1 5 30 15:55 16:55 P-454 12 P-455 MCN 1 P-456 P-457 WDHA VIP 1 P-458 MALT 1 P-459 FNH P-460 2 1 5 30 15:55 16:55 P-461 1 P-462 P-463 IgG4 1 P-464 13C P-465 P-466 TAE 1-79 -

5 30 15:55 16:55 P-467 P-468 Lymphoplasmacytic sclerosing pancratitis P-469 2 P-470 P-471 P-472 2 1 P-473 1 5 30 15:55 16:55 P-474 TS-1 P-475 RAD001 gemcitabine P-476 CD-DST P-477 5-FU+CDDP1 P-478 Gemcitabine Oxaliplatin GemOx CR P-479 Gemcitabine GEM1 P-480 Gemcitabine + S-1 5 29 16:10 17:10 NET GIST P-481 1 P-482 Large cell neuroendocrine carcinoma 1 P-483 7 1-80 -

P-484 GIST P-485 GIST5 5 29 16:10 17:10 NET GIST P-486 gastrointestinal stromal tumor GIST P-487 1 P-488 P-489 P-490 5 30 15:55 16:55 P-491 5 1 P-492 1 P-493 1 P-494 P-495 60mm x 38mm Brunner 5 30 15:55 16:55 P-496 1 P-497 P-498 2 P-499 1-81 -